US Patent Issued to SoVarGen on Oct. 28 for "Composition for prevention or treatment of intractable epilepsy comprising mTOR inhibitor" (South Korean Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,453,733, issued on Oct. 28, was assigned to SoVarGen Co. Ltd. (Daejeon, South Korea).

"Composition for prevention or treatment of intractable epilepsy comprising mTOR inhibitor" was invented by Jeong Ho Lee (Daejeon, South Korea), Jae Seok Lim (Daejeon, South Korea), Woo-Il Kim (Daejeon, South Korea), Dong Seok Kim (Seoul, South Korea), Hoon Chul Kang (Seoul, South Korea) and Se Hoon Kim (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided is a use of the prophylaxis, amelioration or therapy of intractable epilepsy, for example, Focal Cortical Dysplasia (FCD)."

The patent was filed on Feb. 9, 2021, under Application No. 17/171,90...